In stage I LUSC, the number of stromal CD204+ tumor-associated macrophages (TAMs) was reported to be significantly higher in patients with PDPN+ CAFs than in those with PDPN− CAFs [50]. The gene discussed is PDPN; the disease is neoplasm.